We recently reported on the improvement of fasting glucose in diabetic chronic myeloid leukaemia (CML) patients treated with imatinib. 1 We here describe a further case on treatment with imatinib, in which we sequentially tested, in addition to the fasting glucose (FG) levels, the glycosilated haemoglobin fraction (Hb A1c) and plasma insulin.
Reduction of glycosylated hemoglobin with stable insulin levels in a diabetic patient with chronic myeloid leukemia responsive to imatinib / M., Breccia; Muscaritoli, Maurizio; Alimena, Giuliana. - In: HAEMATOLOGICA. - ISSN 1592-8721. - STAMPA. - 90 Suppl:(2005), p. ECR21.
Reduction of glycosylated hemoglobin with stable insulin levels in a diabetic patient with chronic myeloid leukemia responsive to imatinib.
M. Breccia;MUSCARITOLI, Maurizio;ALIMENA, Giuliana
2005
Abstract
We recently reported on the improvement of fasting glucose in diabetic chronic myeloid leukaemia (CML) patients treated with imatinib. 1 We here describe a further case on treatment with imatinib, in which we sequentially tested, in addition to the fasting glucose (FG) levels, the glycosilated haemoglobin fraction (Hb A1c) and plasma insulin.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
